Mead Johnson Nutrition Company MJN unveils its next round of earnings this Thursday, October 27, 2011. Get the latest predictions in Benzinga's essential guide to the company's third quarter earnings report.
Earnings and Revenue:
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 | Q1 | Q4 | Q3 |
EPS Estimate | $0.69 | $0.71 | $0.56 | $0.58 |
EPS Actual | $0.72 | $0.76 | $0.57 | $0.57 |
Stock Performance:
Average Stock Rating:
Competitors:
- AMERICAN DAIRY (ADY): Hold with a $0.24 recent quarter EPS
- Dean Foods Company (DF): Hold with a $0.18 recent quarter EPS
- Lifeway Foods (LWAY): Moderate Buy with a $0.02 recent quarter EPS
- Synutra International (SYUT): Strong Buy with a -$0.17 recent quarter EPS
The medical products company's industry has seen price/earnings growth of 1.5% during the current fiscal year.
Finally, a description of the company's main areas of operation: Mead Johnson Nutrition provides pediatric nutrition and related products which help improve the health and development of infants and children around the world.
Take Action:
Now that you have reviewed all the numbers, be ready to move if the upcoming Mead Johnson Nutrition Company earnings report has any surprises. Also, come back to Benzinga after the announcement for a full recap and a guide to your next steps.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.